Gupta Sanjeev

SEC source: 0000738214-26-000031 · primary_doc.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,385,000

Underlying: Common Stock · 200,000 shares

Expires 2036-03-19

F1 · derivative.exercise_date: 1/12th of the option shares vest every three months from the grant date

SEC source: 0001593968-25-000098 · primary_01.xml · derivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,205,000

Underlying: Common Stock · 165,568 shares

Expires 2035-01-16

F1 · derivative.exercise_date: 1/12th of the option shares vest every three months from the grant date

SEC source: 0001593968-25-000098 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,039,432

Underlying: Common Stock · 34,432 shares

Expires 2035-01-16

F1 · derivative.exercise_date: 1/12th of the option shares vest every three months from the grant date

SEC source: 0001593968-24-000129 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,005,000

Underlying: Common stock and Series B Preferred · 200,000 shares

Expires 2034-01-18

F1 · derivative.exercise_date: 1/12th of the option shares vest every three months from the grant date

F2 · derivative.underlying: Option is exercisable for common stock

SEC source: 0001593968-23-000098 · primary_01.xml · derivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,500

Underlying: Common stock and Series B Preferred · 137,500 shares

Expires 2033-01-05

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.75 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. The grant was split into 137,500 non-qualified Incentive stock options (NQSO) and 12,500 as Incentive Stock Options (ISO) under the IRC 422(d) adjustment.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.75 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. The grant was split into 137,500 non-qualified Incentive stock options (NQSO) and 12,500 as Incentive Stock Options (ISO) under the IRC 422(d) adjustment.

SEC source: 0001593968-23-000098 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common stock and Series B Preferred · 12,500 shares

Expires 2033-01-05

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.75 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. The grant was split into 137,500 non-qualified Incentive stock options (NQSO) and 12,500 as Incentive Stock Options (ISO) under the IRC 422(d) adjustment.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.75 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. The grant was split into 137,500 non-qualified Incentive stock options (NQSO) and 12,500 as Incentive Stock Options (ISO) under the IRC 422(d) adjustment.

SEC source: 0001593968-22-001371 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock and Series B Preferred · 50,000 shares

Expires 2032-08-18

F1 · shares: The Reporting person was granted 50,000 options on 8/18/2022 with three year vesting period.

SEC source: 0001593968-22-000197 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2032-01-06

F1 · shares: The Reporting person was granted 100,000 ISO options on 1/6/2022 with three year vesting period.

SEC source: 0001593968-21-002440 · primary_01.xml · derivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,066

Underlying: Common stock and Series B Preferred · 3,066 shares

Expires 2031-11-18

F2 · shares: The Reporting person was granted 3066 ISO options on 11/18/2021 with three year vesting period.

SEC source: 0001593968-21-002440 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,434

Underlying: Common stock and Series B Preferred · 9,434 shares

Expires 2031-11-18

F1 · shares: The Reporting person was granted 9,434 NQSO options on 11/18/2021 with three year vesting period.

SEC source: 0001593968-21-002138 · primary_01.xml · derivative · entry 13

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 24,800 shares

Expires 2030-03-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-21-002138 · primary_01.xml · derivative · entry 11

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2027-01-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 10

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 9

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,014

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 8

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,892

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 7

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,643

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 6

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,892

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,014

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-21-002138 · primary_01.xml · derivative · entry 12

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 5

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,889

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 4

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,014

SEC source: 0001593968-21-002138 · primary_01.xml · nonDerivative · entry 3

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,014

F1 · balance_after: The Reporting Person beneficially owned 10,889 shares of the Company before 9/15/2021 issuance. 2,125 shares were held from the 9/15/2021 issuance. As of the date of this filing, the Reporting Person beneficially owned 13,014 shares of the Company.

SEC source: 0001593968-21-001637 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,731

Underlying: Common stock and Series B Preferred · 61,165 shares

Expires 2026-05-21

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 7

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,889

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 6

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,158

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F4 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.

SEC source: 0001593968-21-001142 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,551

Underlying: Common stock and Series B Preferred · 37,700 shares

Expires 2030-03-28

F1 · price: The 3-28-2020 option grant was exercised and sold through 10b5-1 plan.

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 5

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,993

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 4

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,442

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

F4 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.

SEC source: 0001593968-21-000981 · primary_01.xml · derivative · entry 5

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,361

Underlying: Common stock and Series B Preferred · 49,346 shares

Expires 2028-01-18

SEC source: 0001593968-21-000981 · primary_01.xml · derivative · entry 3

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,899

Underlying: Common stock and Series B Preferred · 29,035 shares

Expires 2027-11-16

SEC source: 0001593968-21-000981 · primary_01.xml · derivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,177

Underlying: Common stock and Series B Preferred · 15,823 shares

Expires 2022-05-21

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 20,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $4.35 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 3

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,934

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.

SEC source: 0001593968-21-000981 · primary_01.xml · derivative · entry 4

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,707

Underlying: Common stock and Series B Preferred · 96,639 shares

Expires 2028-01-18

SEC source: 0001593968-21-000981 · primary_01.xml · nonDerivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 2

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,204

F2 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F4 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 0 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the June 16, 2021 option exercise in which the Reporting Person sold all but 10,889 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 143 shares of the Issuers common stock.

SEC source: 0001593968-21-000960 · primary_01.xml · nonDerivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · shares: Common stock acquired exercising options in 2014.

SEC source: 0001593968-21-002313 · primary_01.xml · nonDerivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,497

F1 · kind: These shares were withheld by the Issuer in connection with the Reporting Persons exercise of stock options.

SEC source: 0001593968-21-000101 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common stock and Series B Preferred · 125,000 shares

Expires 2031-01-07

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 125,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 125,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-20-000916 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common stock and Series B Preferred · 150,000 shares

Expires 2030-03-28

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 150,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.60 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-20-000140 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2030-01-09

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.86 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-19-001370 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2029-06-05

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at and Exercise Price of $0.92 per share, and subject to the terms of the Stock Option Agreement between Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at and Exercise Price of $0.92 per share, and subject to the terms of the Stock Option Agreement between Reporting Person and the Company.

SEC source: 0001593968-19-000137 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2029-01-07

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-18-000795 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock and Series B Preferred · 60,000 shares

Expires 2023-05-17

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Qualified Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $1.71 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Qualified Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $1.71 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-18-000174 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2028-01-18

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

F2 · derivative.underlying_shares: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

F2 · balance_after: Grant of Incentive Stock Option under the Aemetis, Inc. Amended and Restated 2007 Stock Plan to purchase 100,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $0.70 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company.

SEC source: 0001593968-17-001252 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock and Series B Preferred · 30,000 shares

Expires 2027-11-16

F1 · derivative.exercise_price: Stock Options granted with immediate vesting

SEC source: 0001593968-17-000132 · primary_01.xml · derivative · entry 1

Gupta Sanjeev · CIK 0001460201 · Executive Vice President, MD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock and Series B Preferred · 100,000 shares

Expires 2027-01-19

F1 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.